Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
2004 1
2006 1
2009 1
2010 1
2016 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.
Pérez-Balbuena AL, Ochoa-Tabares JC, Belalcazar-Rey S, Urzúa-Salinas C, Saucedo-Rodríguez LR, Velasco-Ramos R, Suárez-Sánchez RG, Rodríguez-Carrizalez AD, Oregón-Miranda AA. Pérez-Balbuena AL, et al. BMC Ophthalmol. 2016 Sep 20;16(1):164. doi: 10.1186/s12886-016-0343-9. BMC Ophthalmol. 2016. PMID: 27645318 Free PMC article. Clinical Trial.
METHODS: A phase III, double-blind, masked, controlled, multicenter, clinical trial of 148 subjects, randomized to either a fixed combination of xanthan gum 0.09 % and chondroitin sulfate 0.1 % (XG/CS) ophthalmic solution (n = 76) or a fixed combination of polyethylene
METHODS: A phase III, double-blind, masked, controlled, multicenter, clinical trial of 148 subjects, randomized to either a fixed combinatio …
Comparison of initial treatment response to two enhanced-viscosity artificial tears.
Noecker RJ. Noecker RJ. Eye Contact Lens. 2006 May;32(3):148-52. doi: 10.1097/01.icl.0000181819.63425.a6. Eye Contact Lens. 2006. PMID: 16702870 Clinical Trial.
PURPOSE: To compare the effectiveness of 1.0% carboxymethylcellulose (CMC) (Refresh Liquigel, Allergan, Inc., Irvine, CA) and propylene glycol/polyethylene glycol 400 (PG-HPG) (Systane, Alcon, Fort Worth, TX) in providing relief of dry eye sympt …
PURPOSE: To compare the effectiveness of 1.0% carboxymethylcellulose (CMC) (Refresh Liquigel, Allergan, Inc., Irvine, CA) and propylene
Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
Davitt WF, Bloomenstein M, Christensen M, Martin AE. Davitt WF, et al. J Ocul Pharmacol Ther. 2010 Aug;26(4):347-53. doi: 10.1089/jop.2010.0025. J Ocul Pharmacol Ther. 2010. PMID: 20653478 Clinical Trial.
Evaluations of corneal and conjunctival staining and other ocular symptoms of dry eye were conducted for a new formulation of polyethylene glycol 400/propylene glycol-based lubricant eye drops containing hydroxypropyl guar as a gelling agent (Te …
Evaluations of corneal and conjunctival staining and other ocular symptoms of dry eye were conducted for a new formulation of polyethylen
Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye.
Christensen MT, Cohen S, Rinehart J, Akers F, Pemberton B, Bloomenstein M, Lesher M, Kaplan D, Meadows D, Meuse P, Hearn C, Stein JM. Christensen MT, et al. Curr Eye Res. 2004 Jan;28(1):55-62. doi: 10.1076/ceyr.28.1.55.23495. Curr Eye Res. 2004. PMID: 14704914 Clinical Trial.
PURPOSE: To evaluate the efficacy of a new lubricant eye drop containing polyethylene glycol 400 and propylene glycol demulcents with hydroxypropyl-guar as a gelling agent (Test Product) to a system with carboxymethylcellulose (Control Product) …
PURPOSE: To evaluate the efficacy of a new lubricant eye drop containing polyethylene glycol 400 and propylene
Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients.
Rolando M, Autori S, Badino F, Barabino S. Rolando M, et al. J Ocul Pharmacol Ther. 2009 Jun;25(3):271-8. doi: 10.1089/jop.2008.0026. J Ocul Pharmacol Ther. 2009. PMID: 19366323 Clinical Trial.
PURPOSE: The aim of this study was to evaluate the efficacy of a non-Newtonian tear substitute containing 0.4% polyethylene glycol 400 (PEG 400) and 0.3% propylene glycol in an 0.18% hydroxypropyl-guar (HPG) containing vehicle (Systane Lubricant …
PURPOSE: The aim of this study was to evaluate the efficacy of a non-Newtonian tear substitute containing 0.4% polyethylene glycol
Influence of soft gelatin on digoxin absorption.
O'Grady J, Johnson BF, Bye C, Sabey GA. O'Grady J, et al. Br J Clin Pharmacol. 1978 May;5(5):461-3. Br J Clin Pharmacol. 1978. PMID: 656286 Free PMC article. Clinical Trial.
1 The influence of encapsulation in soft gelatin on the absorption of digoxin from a solvent mixture of polyethylene glycol 400 90% W/W, ethanol 6% W/W, propylene glycol 3% W/W and water 1% W/W was studied in eight healthy volunteers. 2 Each vol …
1 The influence of encapsulation in soft gelatin on the absorption of digoxin from a solvent mixture of polyethylene glycol
Clinical evaluation of tear substitute utility after anti-VEGF intravitreal injection.
Carlo C, Poddi M, Mocini S, Boni N, Damiani F, Battini MA, Mirabella G, Tataranno M. Carlo C, et al. Eur J Ophthalmol. 2024 Nov;34(6):1847-1851. doi: 10.1177/11206721241234427. Epub 2024 Feb 22. Eur J Ophthalmol. 2024. PMID: 38389327 Clinical Trial.
PURPOSE: The purpose of this study is to evaluate the role of a polyethylene glycol 400 - propylene glycol - hydroxypropyl guar - hyaluronic acid eye drops in relieving the symptoms of dry eye syndrome after anti-VEGF intravitreal injection. ...
PURPOSE: The purpose of this study is to evaluate the role of a polyethylene glycol 400 - propylene glycol